Opexa Therapeutics (OPXA) to Ring the NASDAQ Stock Market Closing Bell
5/24/2013 9:31:08 AM
More...
|
Opexa Therapeutics (OPXA) Reports First Quarter 2013 Financial Results and Provides Corporate Update
5/14/2013 7:38:05 AM
More...
|
Opexa Therapeutics (OPXA) Reports Year End 2012 Financial Results and Provides Corporate Update
3/29/2013 6:24:32 AM
More...
|
Opexa Therapeutics (OPXA) to Present at the 6th Annual European Life Science CEO Forum
3/4/2013 6:13:55 AM
More...
|
Opexa Therapeutics (OPXA) Announces Pricing of Common Stock and Warrant Offering
2/7/2013 9:58:54 AM
More...
|
Opexa Therapeutics (OPXA) to Present at the 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/7/2013 6:36:38 AM
More...
|
Merck Serono, Opexa Therapeutics (OPXA) Form Pact That Could Net Opexa $225 Million
2/5/2013 7:31:43 AM
More...
|
Opexa Therapeutics (OPXA) Closes Private Note Offering
1/24/2013 8:55:33 AM
More...
|
Opexa Therapeutics (OPXA) Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement
1/15/2013 9:33:14 AM
More...
|
Opexa Therapeutics (OPXA) to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
11/13/2012 10:29:34 AM
More...
|
|